Table 1

Histomorphometric measures

GroupBV (%)Md.V (%)Tb.N (mm−1)Tb.Sp (μm)Tb.Th (μm)OV (%)OS (%)O.Th (μm)ES (%)
Intact16.93 ± 0.2316.88 ± 0.242.83 ± 0.07294.9 ± 8.060.02 ± 1.060.28 ± 0.053.85 ± 0.602.18 ± 0.13*1.05 ± 0.25
OVX10.49 ± 0.7810.11 ± 0.751.80 ± 0.09502.3 ± 27.258.03 ± 2.293.52 ± 0.6420.86 ± 2.624.89 ± 0.582.73 ± 0.63
OVX + EXE (20 mg/kg)13.44 ± 0.6713.52 ± 0.592.12 ± 0.10411.8 ± 19.664.27 ± 1.330.77 ± 0.116.83 ± 0.864.03 ± 0.611.72 ± 0.61
OVX + EXE (50 mg/kg)17.92 ± 0.9017.84 ± 0.903.00 ± 0.17277.8 ± 18.859.83 ± 0.730.43 ± 0.054.09 ± 0.623.32 ± 0.26*1.11 ± 0.27
OVX + EXE (100 mg/kg)17.09 ± 1.1117.04 ± 1.102.89 ± 0.14289.7 ± 17.459.09 ± 2.690.31 ± 0.023.58 ± 0.332.81 ± 0.47*1.02 ± 0.24
OVX +17-H-EXE (20 mg/kg)17.64 ± 0.9217.56 ± 0.912.69 ± 0.16311.72 ± 21.166.21 ± 3.920.40 ± 0.084.09 ± 0.513.27 ± 0.38*1.14 ± 0.21
  • NOTE. Data are mean ± SE (n = 5).

  • Abbreviations: BV, bone volume; Md.V, mineralized trabecular bone volume; Tb.N, trabecular number; Tb.Sp, trabecular separation; Tb.Th, trabecular thickness; OV, osteoid volume; OS, osteoid surface; O.Th, osteoid thickness; ES, eroded surface.

  • * P < 0.005 versus OVX rats.

  • P < 0.05 versus OVX rats.

  • Significant difference from all other groups (P< 0.001).